Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Essential components of an effective transition from paediatric to adult neurologist care for adolescents with Duchenne muscular dystrophy; a consensus derived using the Delphi methodology in Eastern Europe, Greece and Israel

MJ. Molnar, L. Szabó, OA. Vladacenco, AM. Cobzaru, T. Dor, A. Dori, G. Papadimas, L. Juříková, I. Litvinenko, I. Tournev, C. Dixon

. 2024 ; 19 (1) : 260. [pub] 20240709

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019776

PURPOSE: An increasing number of patients with Duchenne muscular dystrophy (DMD) now have access to improved standard of care and disease modifying treatments, which improve the clinical course of DMD and extend life expectancy beyond 30 years of age. A key issue for adolescent DMD patients is the transition from paediatric- to adult-oriented healthcare. Adolescents and adults with DMD have unique but highly complex healthcare needs associated with long-term steroid use, orthopaedic, respiratory, cardiac, psychological, and gastrointestinal problems meaning that a comprehensive transition process is required. A sub-optimal transition into adult care can have disruptive and deleterious consequences for a patient's long-term care. This paper details the results of a consensus amongst clinicians on transitioning adolescent DMD patients from paediatric to adult neurologists that can act as a guide to best practice to ensure patients have continuous comprehensive care at every stage of their journey. METHODS: The consensus was derived using the Delphi methodology. Fifty-three statements were developed by a Steering Group (the authors of this paper) covering seven topics: Define the goals of transition, Preparing the patient, carers/parents and the adult centre, The transition process at the paediatric centre, The multidisciplinary transition summary - Principles, The multidisciplinary transition summary - Content, First visit in the adult centre, Evaluation of transition. The statements were shared with paediatric and adult neurologists across Central Eastern Europe (CEE) as a survey requesting their level of agreement with each statement. RESULTS: Data from 60 responders (54 full responses and six partial responses) were included in the data set analysis. A consensus was agreed across 100% of the statements. CONCLUSIONS: It is hoped that the findings of this survey which sets out agreed best practice statements, and the transfer template documents developed, will be widely used and so facilitate an effective transition from paediatric to adult care for adolescents with DMD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019776
003      
CZ-PrNML
005      
20241024110941.0
007      
ta
008      
241015s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13023-024-03270-2 $2 doi
035    __
$a (PubMed)38982500
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Molnar, Maria Judit $u Director of Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary
245    10
$a Essential components of an effective transition from paediatric to adult neurologist care for adolescents with Duchenne muscular dystrophy; a consensus derived using the Delphi methodology in Eastern Europe, Greece and Israel / $c MJ. Molnar, L. Szabó, OA. Vladacenco, AM. Cobzaru, T. Dor, A. Dori, G. Papadimas, L. Juříková, I. Litvinenko, I. Tournev, C. Dixon
520    9_
$a PURPOSE: An increasing number of patients with Duchenne muscular dystrophy (DMD) now have access to improved standard of care and disease modifying treatments, which improve the clinical course of DMD and extend life expectancy beyond 30 years of age. A key issue for adolescent DMD patients is the transition from paediatric- to adult-oriented healthcare. Adolescents and adults with DMD have unique but highly complex healthcare needs associated with long-term steroid use, orthopaedic, respiratory, cardiac, psychological, and gastrointestinal problems meaning that a comprehensive transition process is required. A sub-optimal transition into adult care can have disruptive and deleterious consequences for a patient's long-term care. This paper details the results of a consensus amongst clinicians on transitioning adolescent DMD patients from paediatric to adult neurologists that can act as a guide to best practice to ensure patients have continuous comprehensive care at every stage of their journey. METHODS: The consensus was derived using the Delphi methodology. Fifty-three statements were developed by a Steering Group (the authors of this paper) covering seven topics: Define the goals of transition, Preparing the patient, carers/parents and the adult centre, The transition process at the paediatric centre, The multidisciplinary transition summary - Principles, The multidisciplinary transition summary - Content, First visit in the adult centre, Evaluation of transition. The statements were shared with paediatric and adult neurologists across Central Eastern Europe (CEE) as a survey requesting their level of agreement with each statement. RESULTS: Data from 60 responders (54 full responses and six partial responses) were included in the data set analysis. A consensus was agreed across 100% of the statements. CONCLUSIONS: It is hoped that the findings of this survey which sets out agreed best practice statements, and the transfer template documents developed, will be widely used and so facilitate an effective transition from paediatric to adult care for adolescents with DMD.
650    _2
$a lidé $7 D006801
650    12
$a Duchennova muskulární dystrofie $x terapie $7 D020388
650    _2
$a mladiství $7 D000293
650    12
$a delfská metoda $7 D003697
650    _2
$a neurologové $7 D000072141
650    _2
$a dospělí $7 D000328
650    _2
$a přechod k lékaři pro dospělé $7 D060305
650    _2
$a konsensus $7 D032921
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
651    _2
$a Izrael $7 D007557
651    _2
$a Řecko $7 D006115
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Szabó, Léna $u Pediatric Center, Semmelweis University, Budapest, Hungary
700    1_
$a Vladacenco, Oana Aurelia $u University of Medicine and Pharmacy Bucharest, Bucharest, Romania
700    1_
$a Cobzaru, Ana Maria $u University Emergency Hospital Bucharest, Bucharest, Romania
700    1_
$a Dor, Talya $u Pediatric Neurology Unit, Hadassah University Hospital, Jerusalem, Israel
700    1_
$a Dori, Amir $u Sheba Medical Center at Tel-Hashomer, Neurology Clinic, Ramat-Gan, Israel
700    1_
$a Papadimas, Georgios $u First Department of Neurology, University of Athens, Athens, Greece
700    1_
$a Juříková, Lenka $u Department of Pediatric Neurology, University Hospital Brno, Brno, Czech Republic
700    1_
$a Litvinenko, Ivan $u Pediatric Neurology Department, SHATPD "Prof. Dr. Ivan Mitev", Sofia, Bulgaria
700    1_
$a Tournev, Ivailo $u Department of Neurology, University Hospital Aleksandrovska, Medical University, Sofia, Bulgaria $u Department of Cognitive Science and Psychology, New Bulgarian University, Sofia, Bulgaria
700    1_
$a Dixon, Craig $u MASS Team, London, UK. craig@mass-team.com $1 https://orcid.org/0009000869575693
773    0_
$w MED00165365 $t Orphanet journal of rare diseases $x 1750-1172 $g Roč. 19, č. 1 (2024), s. 260
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38982500 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110935 $b ABA008
999    __
$a ok $b bmc $g 2202167 $s 1231749
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 19 $c 1 $d 260 $e 20240709 $i 1750-1172 $m Orphanet journal of rare diseases $n Orphanet J Rare Dis $x MED00165365
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Možnosti archivace